The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer
- 1 April 2006
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 16 (2) , 124-136
- https://doi.org/10.1016/j.semcancer.2005.11.006
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (1 R01 CA104547-01A1, DAMD17-02-1-0361, R33 CA97728-02, R37 AI53102)
This publication has 147 references indexed in Scilit:
- IntroductionSeminars in Immunology, 2004
- CD4+CD25+ TR Cells Suppress Innate Immune Pathology Through Cytokine-dependent MechanismsThe Journal of Experimental Medicine, 2003
- Inflammation and cancerNature, 2002
- Functional significance of the perforin/granzyme cell death pathwayNature Reviews Immunology, 2002
- Transforming growth factor-β in T-cell biologyNature Reviews Immunology, 2002
- Deletion of Idiotype (Id)-Specific T Cells in Multiple MyelomaActa Oncologica, 2000
- Clonal deletion of thymocytes as a tumor escape mechanismInternational Journal of Cancer, 1998
- Interleukin 10 Secretion and Impaired Effector Function of Major Histocompatibility Complex Class II–restricted T Cells Anergized In VivoThe Journal of Experimental Medicine, 1998
- Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytomaEuropean Journal of Immunology, 1996
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992